Ian Sanne, MBBCh
Adjunct Associate Professor
Boston University School of Public Health
Dept of Global Health

MBBCh, University of the Witwatersrand




Professor Ian Matthias Sanne is a South African born infectious diseases doctor and has been involved in HIV and TB research since qualifying as internist in 1996. Since 2003 he has led the Wits HIV Research Group Clinical Trials Unit, and from 2003- 2012 led the Adult Treatment Research Site. He currently holds the AIDS Clinical Trials Group International Vice-Chair position and is responsible for overseeing the network’s research at 25 international sites in 13 countries and assisting in the prioritization of the research agenda. The focus of his research attention is an integrated program of HIV and TB research from prospective phase I-IV clinical trials, conducted predominantly through international collaborations with the NIH, EDCTP, Global TB Alliance and the Medical Research Council of South Africa. The key focus in the ACTG collaboration is prospective research to inform diagnostic, prevention and treatment interventions to optimize the diagnosis and treatment of HIV and tuberculosis. In addition through programs of implementation sciences and monitoring evaluation data produced as part of the Right to Care PEPFAR implementation program epidemiologic and health economic evaluation of health care interventions. The overall aim is to develop evidence based health system strengthening interventions to address the public health emergencies facing the resource poor setting. At the intersection of clinical care, and clinical trial administration, Professor Sanne continues to provide expertise to the ACTG leadership from the experience gained as the founding Director and Chief Executive Officer of Right to Care.

2013 University of the Witwatersrand: Faculty of Health Sciences Research Award
2011 University of the Witwatersrand: Faculty of Health Sciences Research Award
2009 Health Management Organization: Top Health Care Manager
2008 ACTG Scientific Agenda Steering Committee: Outstanding Service Award
2005 Mail and Guardian: Top 100 Young Leaders in South Africa

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. David A, Scott L, Jugwanth S, Gededzha M, Kahamba T, Zwane N, Mampeule N, Sanne I, Stevens W, Mayne ES. Operational characteristics of 30 lateral flow immunoassays used to identify COVID-19 immune response. J Immunol Methods. 2021 Jul 06; 496:113096. PMID: 34242653; DOI: 10.1016/j.jim.2021.113096;
     
  2. Gededzha MP, Mampeule N, Jugwanth S, Zwane N, David A, Burgers WA, Blackburn JM, Grove JS, George JA, Sanne I, Scott L, Stevens W, Mayne ES. Performance of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies in South Africa. PLoS One. 2021; 16(6):e0252317. PMID: 34161348; DOI: 10.1371/journal.pone.0252317;
     
  3. Dorman SE, Nahid P, Kurbatova EV, Phillips PPJ, Bryant K, Dooley KE, Engle M, Goldberg SV, Phan HTT, Hakim J, Johnson JL, Lourens M, Martinson NA, Muzanyi G, Narunsky K, Nerette S, Nguyen NV, Pham TH, Pierre S, Purfield AE, Samaneka W, Savic RM, Sanne I, Scott NA, Shenje J, Sizemore E, Vernon A, Waja Z, Weiner M, Swindells S, Chaisson RE. Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis. N Engl J Med. 2021 05 06; 384(18):1705-1718. PMID: 33951360
     
  4. Nichols BE, Jamieson L, Zhang SRC, Rao GA, Silal S, Pulliam JRC, Sanne I, Meyer-Rath G. The Role of Remdesivir in South Africa: Preventing COVID-19 Deaths Through Increasing Intensive Care Unit Capacity. Clin Infect Dis. 2021 05 04; 72(9):1642-1644.View Related Profiles. PMID: 32628744; DOI: 10.1093/cid/ciaa937;
     
  5. Hoffman RM, Moyo C, Balakasi KT, Siwale Z, Hubbard J, Bardon A, Fox MP, Kakwesa G, Kalua T, Nyasa-Haambokoma M, Dovel K, Campbell PM, Tseng CH, Pisa PT, Cele R, Gupta S, Benade M, Long L, Xulu T, Sanne I, Rosen S. Multimonth dispensing of up to 6 months of antiretroviral therapy in Malawi and Zambia (INTERVAL): a cluster-randomised, non-blinded, non-inferiority trial. Lancet Glob Health. 2021 05; 9(5):e628-e638.View Related Profiles. PMID: 33865471
     
  6. Makatsa MS, Tincho MB, Wendoh JM, Ismail SD, Nesamari R, Pera F, de Beer S, David A, Jugwanth S, Gededzha MP, Mampeule N, Sanne I, Stevens W, Scott L, Blackburn J, Mayne ES, Keeton RS, Burgers WA. SARS-CoV-2 Antigens Expressed in Plants Detect Antibody Responses in COVID-19 Patients. Front Plant Sci. 2021; 12:589940. PMID: 33868324; DOI: 10.3389/fpls.2021.589940;
     
  7. Jo Y, Jamieson L, Edoka I, Long L, Silal S, Pulliam JRC, Moultrie H, Sanne I, Meyer-Rath G, Nichols BE. Cost-effectiveness of Remdesivir and Dexamethasone for COVID-19 Treatment in South Africa. Open Forum Infect Dis. 2021 Mar; 8(3):ofab040.View Related Profiles. PMID: 33732750; DOI: 10.1093/ofid/ofab040;
     
  8. Evans D, van Rensburg C, Govathson C, Ivanova O, Rieß F, Siroka A, Sillah AK, Ntinginya NE, Jani I, Sathar F, Rosen S, Sanne I, Rachow A, Lönnroth K. Adaptation of WHO's generic tuberculosis patient cost instrument for a longitudinal study in Africa. Glob Health Action. 2021 01 01; 14(1):1865625. PMID: 33491593; DOI: 10.1080/16549716.2020.1865625;
     
  9. Gray G, Van der Heever A, Madhi SS, McIntyre J, Kana B, Stevens W, Sanne I, Richards G, Abdullah F, Mendelson M, Dasoo A, Nel J, Wulfsohn A, Blumberg L, Venter F. The Scientists' Collective 10-point proposal for equitable and timeous access to COVID-19 vaccine in South Africa. S Afr Med J. 2020 12 14; 0(0):13163. PMID: 33334389
     
  10. Gray G, Van der Heever A, Madhi S, McIntyre J, Kana B, Stevens W, Sanne I, Richards G, Abdullah F, Mendelson M, Dasoo A, Nel J, Wulfsohn A, Blumberg L, Venter F. The Scientists' Collective 10-point proposal for equitable and timeous access to COVID-19 vaccine in South Africa. S Afr Med J. 2020 12 14; 111(2):89-94. PMID: 33944712
     
Showing 10 of 221 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 221 publications over 22 distinct years, with a maximum of 26 publications in 2013

YearPublications
19941
20012
20021
20035
20043
20054
20063
20073
20089
20099
201018
201118
201218
201326
201420
201513
201621
201714
20188
20198
20209
20218

Contact for Mentoring:
Sanne's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department